Sofos Investments, Inc.
- SEC CIK
- 0001741736
- Latest filing
- May 8, 2026
ASND holding history
Ascendis Pharma A/S in every 13F filed by Sofos Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ASND overviewAll 13F holders of ASNDFull Q1 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −2−100.0% | Sold out | Holders |
| Q4 2023 | 2 | $212 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2 | $147 | <0.1% | −87−97.8% | Reduced | Holders |
| Q2 2023 | 89 | $47 | <0.1% | −18−16.8% | Reduced | Holders |
| Q1 2023 | 107 | $181 | <0.1% | −15−12.3% | Reduced | Holders |
| Q4 2022 | 122 | $35 | <0.1% | −187−60.5% | Reduced | Holders |
| Q3 2022 | 309 | – | – | +30+10.8% | Added | Holders |
| Q2 2022 | 279 | – | – | −72−20.5% | Reduced | Holders |
| Q1 2022 | 351 | – | – | −3,564−91.0% | Reduced | Holders |
| Q4 2021 | 3,915 | – | – | +3,888+14,400.0% | Added | Holders |
| Q3 2021 | 27 | – | – | +27 | New | Holders |